| Quarterly Financials | Mar 2016 | Jun 2016 | Mar 2017 | Jun 2017 | Sept 2017 | Dec 2017 | Mar 2018 | Jun 2018 | Sept 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sept 2019 | Dec 2019 |
Revenue  | 0 | 0 | 3 | 12 | 6 | 5 | 0 | 6 | 15 | 17 | 17 | 9 | 7 | 10 |
| Expenses | 0 | 0 | 2 | 11 | 6 | 5 | 1 | 5 | 15 | 17 | 17 | 9 | 6 | 10 |
| EBITDA | 0 | -0 | 1 | 1 | 0 | 0 | -0 | 1 | 0 | 0 | -1 | 0 | 0 | 0 |
| Operating Profit % | 0 % | 0 % | 26 % | 7 % | 1 % | 1 % | -50 % | 7 % | 2 % | 1 % | -5 % | 2 % | 3 % | 0 % |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 0 | -0 | 1 | 1 | -0 | -0 | -0 | 0 | 0 | 0 | -1 | 0 | 0 | 0 |
| Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | 0 | -0 | 1 | 1 | -0 | -0 | -0 | 0 | 0 | 0 | -1 | 0 | 0 | 0 |
| EPS in ₹ | 0.00 | -0.53 | 0.90 | 1.12 | -0.23 | -0.19 | -0.70 | 0.62 | 0.46 | 0.24 | -1.21 | 0.21 | 0.15 | -0.07 |
Prism Medico & Pharmacy
Prism Medico & Pharmacy
28.79
+1.37
(5.00%)
Market Cap
17.43 Cr
PE Ratio
27.70
Volume
20,851.00
Day High - Low
28.79 - 28.79
52W High-Low
27.42 - 11.62
There are 2 new updates from the company1 day ago
View
Key Fundamentals
Market Cap
17.43 Cr
EPS
0.07
PE Ratio
27.70
PB Ratio
1.10
Book Value
24.89
EBITDA
0.40
Dividend Yield
0.00 %
Industry
Financial Services Sector
NBFC Return on Equity
0.31
Debt to Equity
0.17
Actual
Company News
View All News
Prism Medico and Pharmacy Limited board approved issuance of 75 lakh equity shares and 50 lakh convertible warrants at Rs. 20 each, raising Rs. 25 crore through preferential allotment.
Prism Medico and Pharmacy Limited has scheduled its board meeting for February 13, 2026, to consider and approve Q3FY26 unaudited standalone financial results for quarter ended December 31, 2025.
Prism Medico and Pharmacy Limited submitted confirmation certificate under SEBI Depositories Regulations for Q3FY26 quarter ended December 31, 2025, with no dematerialisation activity.
View more
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
995.90 | #1 6,19,696.97 | 34.39 | #1 69,724.80 | 26.81 | #1 16,780 | -5.62 | 50.92 | |
1,079.40 | 2,03,074.23 | 22.73 | 41,859.50 | 19.61 | 9,423 | -22.13 | 59.20 | |
255.40 | 1,62,259.24 | 101.25 | 2,078.90 | 12.09 | 1,613 | -8.75 | 36.97 | |
1,730.80 | 1,46,054.16 | 30.73 | 26,152.80 | 34.67 | 4,260 | 18.54 | 53.75 | |
3,353.50 | 1,34,632.45 | 15.95 | 20,324.50 | 34.04 | 5,352 | 102.90 | 37.05 | |
774.40 | 73,687.84 | 35.27 | 18,637.10 | 6.60 | 1,916 | 45.25 | 45.22 | |
5,509.50 | 61,212.67 | 29.61 | 8,563.00 | 17.53 | 1,813 | 18.86 | 60.38 | |
374.30 | 52,026.62 | 22.62 | 18,530.50 | 16.03 | 2,261 | -10.03 | 50.05 | |
481.85 | 40,919.93 | #1 11.45 | 4,612.20 | #1 76.63 | 4,241 | -70.06 | 35.06 | |
454.80 | 36,956.45 | 107.88 | 4,222.80 | 34.17 | -98 | #1 703.21 | 48.87 |
Growth Rate
Revenue Growth
139.91 %
Net Income Growth
-
Cash Flow Change
-112.39 %
ROE
-1,133.33 %
ROCE
-97.09 %
EBITDA Margin (Avg.)
-79.55 %
Quarterly Financial Results
Balance Sheet
| Balance Sheet | 2017 | 2018 | 2019 |
| Total Assets | 17 | 16 | 21 |
| Fixed Assets | 10 | 9 | 9 |
| Current Assets | 7 | 4 | 11 |
| Capital Work in Progress | 0 | 0 | 0 |
| Investments | 0 | 3 | 1 |
| Other Assets | 7 | 4 | 11 |
| Total Equity & Liabilities | 17 | 16 | 21 |
| Current Liabilities | 1 | 3 | 8 |
| Non Current Liabilities | 3 | 0 | 0 |
| Total Equity | 13 | 13 | 13 |
| Reserve & Surplus | 7 | 7 | 7 |
| Share Capital | 6 | 6 | 6 |
Cash Flow
| Cash Flow | 2017 | 2018 | 2019 |
| Net Cash Flow | 0 | -1 | -1 |
| Investing Activities | 0 | -3 | 0 |
| Operating Activities | 0 | 4 | -0 |
| Financing Activities | 0 | -2 | -1 |
Share Holding
| % Holding | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 |
| Promoter | 38.02 % | 29.06 % | 23.93 % | 23.93 % | 23.93 % | 23.93 % | 23.93 % | 23.93 % | 23.93 % | 25.00 % | 25.00 % | 25.00 % | 25.00 % | 25.00 % | 25.00 % | 25.00 % | 25.00 % | 25.00 % | 25.00 % | 25.00 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| DIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 54.60 % | 59.85 % | 69.11 % | 68.82 % | 67.22 % | 67.65 % | 64.91 % | 64.89 % | 61.78 % | 63.66 % | 64.02 % | 65.76 % | 67.23 % | 67.30 % | 65.77 % | 65.36 % | 66.07 % | 65.26 % | 65.26 % | 65.63 % |
| Others | 7.38 % | 11.09 % | 6.95 % | 7.25 % | 8.85 % | 8.42 % | 11.16 % | 11.18 % | 14.29 % | 11.34 % | 10.98 % | 9.24 % | 7.77 % | 7.70 % | 9.23 % | 9.64 % | 8.93 % | 9.74 % | 9.74 % | 9.37 % |
| No of Share Holders | 1,243 | 1,900 | 2,790 | 3,731 | 4,245 | 4,168 | 3,890 | 3,328 | 3,558 | 3,610 | 3,465 | 3,650 | 3,792 | 3,866 | 4,107 | 4,178 | 4,302 | 4,306 | 4,315 | 4,306 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 20 Mar 2026 |  Extraordinary General Meeting | NA | 20 Mar 2026 | 22.58 | 27.42 |
| 30 May 2018 |  Change Of Name | NA | 30 May 2018 | 25.50 | 25.50 |
| 30 Sept 2024 |  Annual General Meeting | NA | 30 Sept 2024 | 34.88 | 29.91 |
| 14 Nov 2024 |  Quarterly Result Announcement | NA | 14 Nov 2024 | 26.51 | 27.05 |
| 14 Feb 2025 | Quarterly Result Announcement | NA | 14 Feb 2025 | 17.28 | 16.68 |
| 28 May 2025 | Quarterly Result Announcement | NA | 28 May 2025 | 14.68 | 16.65 |
| 14 Aug 2025 | Quarterly Result Announcement | NA | 14 Aug 2025 | 13.75 | 13.84 |
| 30 Sept 2025 | Annual General Meeting | NA | 30 Sept 2025 | 17.85 | 21.43 |
| 14 Nov 2025 | Quarterly Result Announcement | NA | 14 Nov 2025 | 19.07 | 19.43 |
| 13 Feb 2026 | Quarterly Result Announcement | NA | 13 Feb 2026 | 18.45 | 17.10 |
Announcements
Intimation Regarding Record Date.
1 day ago
1 day agoIntimation Of Book Closure.1 day ago
1 day agoNotice Of Extraordinary General Meeting.2 days ago
2 days agoBoard Meeting Outcome for Outcome Of The Board Meeting - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.4 days ago
4 days agoClarification sought from Prism Medico and Pharmacy Ltd4 days ago
4 days agoBoard Meeting Intimation for Intimation Of Board Meeting.9 days ago
9 days agoBoard Meeting Outcome for Outcome Of The Board Meeting - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.Feb 13, 2026
Feb 13, 2026Board Meeting Intimation for Consideration Approval And Taking On Record The Unaudited Standalone Financial Results Of The Company Along With The Limited Review Report For The Quarter Ended 31St December 2025.Feb 07, 2026
Feb 07, 2026Undertaking Of Functional WebsiteJan 30, 2026
Jan 30, 2026Investor Complaints As Per Regulation 13(3) Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015.Jan 16, 2026
Jan 16, 2026Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 14, 2026
Jan 14, 2026Compliance-57 (5) : intimation after the end of quarterJan 02, 2026
Jan 02, 2026Intimation Under Regulation 57(4) Of SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015.Dec 31, 2025
Dec 31, 2025Closure of Trading WindowDec 24, 2025
Dec 24, 2025Revised Outcome Of The Board Meeting Held On 14Th November 2025.Nov 21, 2025
Nov 21, 2025Board Meeting Outcome for Outcome Of The Board Meeting - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.Nov 14, 2025
Nov 14, 2025Board Meeting Intimation for Intimation Of Board Meeting.Nov 06, 2025
Nov 06, 2025Undertaking Of Functional Website.Oct 27, 2025
Oct 27, 2025Investor Complaints As Per Regulation 13(3) Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015.Oct 17, 2025
Oct 17, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Oct 13, 2025
Oct 13, 2025Shareholder Meeting / Postal Ballot-Scrutinizers ReportOct 01, 2025
Oct 01, 2025Compliance-57 (5) : intimation after the end of quarterOct 01, 2025
Oct 01, 2025Intimation Under Regulation 57(4) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.Oct 01, 2025
Oct 01, 2025Closure of Trading WindowOct 01, 2025
Oct 01, 2025Regulation 30(2) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015 - Proceedings Of 23Rd Annual General Meeting Held On 30Th September 2025.Sep 30, 2025
Sep 30, 2025Outcome Of 23Rd Annual General Meeting Held On 30Th September 2025 At 11:30 A.M. Through Video Conferencing/Other Audio Visual Means.Sep 30, 2025
Sep 30, 2025Revised Outcome Of Board Meeting Dated 14Th August 2025.Sep 12, 2025
Sep 12, 2025Reg. 34 (1) Annual Report.Sep 06, 2025
Sep 06, 2025Intimation Of Record Date.Sep 05, 2025
Sep 05, 2025Intimation Of Book Closure.Sep 05, 2025
Sep 05, 2025Notice Of 23Rd Annual General Meeting.Sep 05, 2025
Sep 05, 2025Annual Report For The Financial Year 2024-2025.Sep 05, 2025
Sep 05, 2025Board Meeting Outcome for Outcome Of The Board Meeting - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.Sep 05, 2025
Sep 05, 2025Board Meeting Intimation for Intimation Of Board Meeting.Sep 01, 2025
Sep 01, 2025Board Meeting Outcome for Outcome Of The Board Meeting - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.Aug 14, 2025
Aug 14, 2025Announcement under Regulation 30 (LODR)-Meeting UpdatesAug 07, 2025
Aug 07, 2025Board Meeting Intimation for Meeting To Be Held On Thursday The 14Th Day Of August 2025 At 01:30 P.M. At The Registered Office Of The Company I.E. Suketi Road Kala Amb Sirmaur Himachal Pradesh-173030.Aug 07, 2025
Aug 07, 2025Board Meeting Outcome for Outcome Of The Board Meeting - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.Aug 04, 2025
Aug 04, 2025Board Meeting Outcome for Outcome Of The Board Meeting - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.Jul 16, 2025
Jul 16, 2025Undertaking Of Functional Website.Jul 15, 2025
Jul 15, 2025Investor Complaints As Per Regulation 13(3) Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015.Jul 15, 2025
Jul 15, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 14, 2025
Jul 14, 2025Revised Outcome Of Board Meeting Dated 28Th May 2025.Jul 01, 2025
Jul 01, 2025Compliance-57 (5) : intimation after the end of quarterJul 01, 2025
Jul 01, 2025Intimation Under Regulation 57(4) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.Jun 30, 2025
Jun 30, 2025Closure of Trading WindowJun 30, 2025
Jun 30, 2025Details Of Related Party Transactions (RPTS) As Per Regulation 23(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.May 28, 2025
May 28, 2025Board Meeting Outcome for Outcome Of The Board Meeting - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.May 28, 2025
May 28, 2025Board Meeting Intimation for Intimation Of Board Meeting As Per Regulation 29(1) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.May 20, 2025
May 20, 2025Submission Of Certificate Under Regulation 40(9) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015 For The Financial Year Ended 31St March 2025.Apr 25, 2025
Apr 25, 2025Technical Indicators
RSI(14)
Overbought 83.83
ATR(14)
Less Volatile 1.45
STOCH(9,6)
Overbought 100.00
STOCH RSI(14)
Overbought 100.00
MACD(12,26)
Bullish 1.05
ADX(14)
Strong Trend 26.79
UO(9)
Bearish 86.24
ROC(12)
Uptrend And Accelerating 51.32
WillR(14)
Overbought 0.00
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
